Theravance Biopharma Inc (TBPH)
Net Debt
-$181.20M
Quarterly · Period ending: · USD
TBPH Net Debt
Latest reported-$181.20Mperiod ending
Latest reported-$181.20Mperiod ending
TBPH Quarterly Net Debt ($0.00 → -$181.20M)
Quarterly net debt
High-resolution chart · PNG
TBPH net debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Debt (USD) |
|---|---|
| -181,197,000 | |
| -214,802,000 | |
| -92,308,000 | |
| -130,178,000 | |
| -235,470,000 | |
| -62,458,000 | |
| 12,023,000 | |
| 21,603,000 | |
| 315,000 | |
| -5,932,000 | |
| 9,614,000 | |
| -20,854,000 | |
| -53,915,000 | |
| -136,471,000 | |
| -246,012,000 | |
| -366,465,000 | |
| 590,670,000 | |
| 578,578,000 | |
| 579,559,000 | |
| 549,812,000 | |
| 463,365,000 | |
| 558,305,000 | |
| 594,790,000 | |
| 575,403,000 | |
| 553,330,000 | |
| 322,367,000 | |
| 452,464,000 | |
| 393,847,000 | |
| 313,323,000 | |
| 271,746,000 | |
| 76,332,000 | |
| 123,348,000 | |
| 120,428,000 | |
| 98,183,000 | |
| 134,766,000 | |
| 132,177,000 | |
| 83,584,000 | |
| 52,997,000 | |
| -122,033,000 | |
| -86,572,000 | |
| -148,363,000 | |
| -128,803,000 | |
| -112,707,000 | |
| -127,114,000 | |
| -97,090,000 | |
| -100,899,000 | |
| -89,215,000 | |
| -122,228,000 | |
| -268,199,000 | |
| -833,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |